This Eli Lilly stock information page provides stock price details and company information, and introduces the company's business activities and key products. Its products are sold in regions including the United States and Puerto Rico, as well as in approximately 90 countries.
Eli Lilly is a pharmaceutical company engaged in the discovery, development, manufacture and sale of human medicines. The article describes the company's business activities, from pharmaceutical research and development through to bringing products to market.
The company's products span areas including cardiometabolic health, oncology and immunology. Representative products include Basaglar, Humalog, Humalog U-100, Jardiance, Mounjaro, Trulicity, Zepbound, Cyramza, Erbitux, Verzenio, Retevmo, Jaypirca, Ebglyss, Olumiant, Omvoh and Taltz. The article also introduces LillyDirect, a patient delivery service in digital healthcare.
The company sells its products in approximately 90 countries, primarily through facilities in the United States and Puerto Rico, as well as in Europe and Asia.